InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by SCHLOSSBERG MARK A, Directeur Juridique. Director active across 2 companies, notably CYTOKINETICS INC. Aggregated, 7 reports have been published. Activity tracked since 19 October 2021. The latest transaction was disclosed on 15 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
30,818 shares@ US$7.030.0025% mcap27.8% of flowCommon StockSEC:0001061983-22-000077:0
4,631 shares@ US$36.830.0020% mcap22.0% of flowCommon StockSEC:0001061983-22-000070:0
3,457 shares@ US$37.630.0015% mcap16.4% of flowCommon StockSEC:0001061983-22-000056:0
1,900 shares0Common StockSEC:0001061983-22-000028:0
1,900 shares0Common StockSEC:0001061983-22-000028
19,979 shares@ US$7.030.0015% mcap16.9% of flowCommon StockSEC:0001061983-21-000241:0
19,979 shares@ US$7.030.0015% mcap100.0% of flowCommon StockSEC:0001061983-21-000241
7 of 7 declarations
About SCHLOSSBERG MARK A
Mark A. Schlossberg is the Senior VP and General Counsel at Cytokinetics Inc. He oversees the company's legal and regulatory matters, contributing to its compliance and legal strategy.
